Jurata Thin Film and CastleVax

About Jurata Thin Film and CastleVax

Jurata is committed to simplifying the supply chain for biologics, vaccines, and advanced therapeutics through innovative thermostable formulations and technology that enhances delivery and administration.

Products & Services

Thermostable Formulations:Formulations in film, liquid, or vialed form that reduce or eliminate the need for cold chain or special handling, simplifying manufacturing and enabling flexible administration without compromising efficacy.

Versatile Platform:A platform that can be integrated into development programs to enhance product attributes for first-in-class therapies and expand access to existing products across diverse modalities.

Specialties

Drug Development Formulation Manufacturing Biologics Vaccines Advanced Therapeutics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 1000000 MR: - FA: $1 million FAN: 1000000	D: 2023-09-19 FD: 2023-09-19	2 investors

Grant Latest

2023-09-19

$1.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tim Obara

Chief Executive Officer

M

Michaela Johnson

Chief Financial Officer

J

Jacob Cain

VP, Science & Technology

I

Irnela Bajrovic

Scientific Co-Founder, Interim CSO

T

Tim Ferguson

General Counsel

K

Kristine Olsen

Head of Human Resources

View 7 more team members with Pro

Unlock Full Team Directory

Recent News